NYSE:BSX - Boston Scientific Stock Price, Price Target & More

Boston Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "BSX."

Boston Scientific Co. (NYSE:BSX) posted its quarterly earnings data on Wednesday, April, 25th. The medical equipment provider reported $0.33 EPS for the quarter, beating the Zacks' consensus estimate of $0.32 by $0.01. The medical equipment provider earned $2.38 billion during the quarter, compared to analysts' expectations of $2.34 billion. Boston Scientific had a return on equity of 25.10% and a net margin of 1.21%. The business's revenue was up 10.1% compared to the same quarter last year. During the same period in the previous year, the business earned $0.29 earnings per share. View Boston Scientific's Earnings History.

Boston Scientific is scheduled to release their next quarterly earnings announcement on Wednesday, July, 25th 2018. View Earnings Estimates for Boston Scientific.

Boston Scientific updated its FY18 earnings guidance on Wednesday, April, 25th. The company provided earnings per share (EPS) guidance of $1.37-1.41 for the period, compared to the Thomson Reuters consensus estimate of $1.37. The company issued revenue guidance of $9.75-9.90 billion (+5-7% organic), compared to the consensus revenue estimate of $9.75 billion.Boston Scientific also updated its Q2 guidance to $0.33-0.35 EPS.

22 equities research analysts have issued 12-month target prices for Boston Scientific's stock. Their predictions range from $27.00 to $38.00. On average, they expect Boston Scientific's stock price to reach $32.8182 in the next twelve months. This suggests that the stock has a possible downside of 3.2%. View Analyst Ratings for Boston Scientific.

22 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Boston Scientific in the last year. There are currently 3 hold ratings, 16 buy ratings and 3 strong buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Boston Scientific saw a drop in short interest in June. As of June 15th, there was short interest totalling 11,140,076 shares, a drop of 22.5% from the May 31st total of 14,367,253 shares. Based on an average daily volume of 13,883,441 shares, the short-interest ratio is currently 0.8 days. Approximately 0.8% of the company's stock are sold short. View Boston Scientific's Current Options Chain.

Some companies that are related to Boston Scientific include 3M (MMM), Becton Dickinson and (BDX), Stryker (SYK), FRESENIUS SE &/S (FSNUY), Baxter International (BAX), ABIOMED (ABMD), ResMed (RMD), Teleflex (TFX), Dexcom (DXCM), Hill-Rom (HRC), ICU Medical (ICUI), Insulet (PODD), Globus Medical (GMED), Haemonetics (HAE) and Penumbra (PEN).

News headlines about BSX stock have been trending somewhat positive recently, Accern reports. Accern identifies positive and negative press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Boston Scientific earned a media sentiment score of 0.09 on Accern's scale. They also assigned headlines about the medical equipment provider an impact score of 46.07 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the near term.

Boston Scientific's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Fred Alger Management Inc. (0.42%), Retirement Systems of Alabama (0.14%), Atalanta Sosnoff Capital LLC (0.09%), Gateway Investment Advisers LLC (0.06%), Bank of Montreal Can (0.06%) and Fjarde AP Fonden Fourth Swedish National Pension Fund (0.03%). Company insiders that own Boston Scientific stock include Arthur C Butcher, Daniel J Brennan, David A Pierce, Eric Francis Yves Thepaut, Jeffrey B Mirviss, John Bradley Sorenson, John E Sununu, Joseph Michael Fitzgerald, Keith D Dawkins, Kevin J Ballinger, Maulik Nanavaty, Michael F Mahoney, Michael P Phalen, Supratim Bose, Timothy A Pratt, Valley Gold Master Fund L Sun and Wendy Carruthers. View Institutional Ownership Trends for Boston Scientific.

BSX stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Retirement Systems of Alabama, Hartford Investment Management Co., Gateway Investment Advisers LLC, Assenagon Asset Management S.A., Xact Kapitalforvaltning AB, Oakbrook Investments LLC and Huntington National Bank. Company insiders that have sold Boston Scientific company stock in the last year include Arthur C Butcher, Daniel J Brennan, David A Pierce, Eric Francis Yves Thepaut, Jeffrey B Mirviss, John Bradley Sorenson, Joseph Michael Fitzgerald, Kevin J Ballinger, Maulik Nanavaty, Michael P Phalen, Supratim Bose, Timothy A Pratt and Wendy Carruthers. View Insider Buying and Selling for Boston Scientific.

BSX stock was purchased by a variety of institutional investors in the last quarter, including Fred Alger Management Inc., Nisa Investment Advisors LLC, Meag Munich Ergo Kapitalanlagegesellschaft MBH, Atalanta Sosnoff Capital LLC, State of Alaska Department of Revenue, IFM Investors Pty Ltd, Fjarde AP Fonden Fourth Swedish National Pension Fund and DnB Asset Management AS. Company insiders that have bought Boston Scientific stock in the last two years include John E Sununu and Valley Gold Master Fund L Sun. View Insider Buying and Selling for Boston Scientific.

Shares of BSX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of BSX stock can currently be purchased for approximately $33.92.

Boston Scientific has a market capitalization of $46.55 billion and generates $9.05 billion in revenue each year. The medical equipment provider earns $105 million in net income (profit) each year or $1.26 on an earnings per share basis. Boston Scientific employs 29,000 workers across the globe.

Boston Scientific's mailing address is 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA, 01752. The medical equipment provider can be reached via phone at 508-683-4000 or via email at [email protected]